Parexel CFO talks earnings, new business
Parexel has announced its financial results for the third quarter of FY16, which remained strong in spite of the complexities associated with smaller clinical trials.
Archives for May 3, 2016
Return to growth: Pfizer thanks Hospira and looks to biosimilars
Pfizer has attributed Hospira’s sterile injectables and biosimilar assets to its return to growth, offsetting 17 quarters of declining sales.
Colorcon building film facility in Brazil to cater for growing pharma market
Colorcon is building a film coating production facility in Indaiatuba, Brazil to service markets in South America.
Marken preps for increased shipment volumes, expands capacity
Marken has announced an expansion of its third party service providers and customs brokers network to prepare for a “significant’ increase in drug, vaccine, API, and ancillary shipment volumes.
Demand led supply: A novel clinical supply approach tailored to today’s trials
Paid for and content provided by Catalent
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier...
Biogen haemophilia spin-out to develop gene therapies and long-acting factors
The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.